Rare diseases affect an estimated 3.5–5.9% of the global population1. Patients dealing with these conditions not only face a direct impact on their health but also frequently encounter challenges in identifying the genetic origins of their disorder. This often leaves them with limited treatment options. However, the field of rare disease diagnosis has seen significant advances with the introduction of next-generation sequencing (NGS). Essential techniques like whole-exome sequencing...
10 results in 0.0029 seconds.
-
Current Advances and Future Directions in Rare Disease Diagnosis
Rare diseases affect an estimated 3.5–5.9% of the global population1. Patients dealing with these conditions not only face a direct impact on their health but also frequently encounter challenges in identifying the genetic origins of their disorder. This often leaves them with limited treatment options. However, the field of rare disease diagnosis has seen significant advances with the introduction of next-generation sequencing (NGS). Essential techniques like whole-exome sequencing... -
Webinar: Unlocking Biological Insights Through Spatial Multiomics Analysis
Unlocking Biological Insights Through Spatial Multiomics Analysis in Partek® Flow®
November 9, 2023
Sessions at: 10:00 a.m.... -
Webinar: Revealing Rare Cell Types Through Single Cell Multiomics - A COVID-19 Study
February 17, 2022
Sessions at 3:00 p.m. SGT, 2:00 p.m. GMT, and 2:00 p.m. EST
The single cell omics field started by profiling gene... -
Revealing Rare Cell Types Through Single Cell Multiomics: A COVID-19 Study
February 17, 2022
3:00 p.m. SGT, 2:00 p.m. GMT, or 2:00 p.m. EST
The single cell omics field started by profiling gene expression... -
Webinar: Revealing Rare Cell Types Through Single Cell Multiomics – A COVID-19 Study
February 17, 2022
3:00 p.m. SGT, 2:00 p.m. GMT, or 2:00 p.m. EST
REGISTRATION
www.partek.com/webinar/revealing-rare-cel... -
Metagenomics, metatranscriptomics, and multi'omics for microbial community studies
Dear all,
due to the COVID-19 pandemic the Physalia course on "Metagenomics, metatranscriptomics, and multi'omics... -
Integrated mRNA and microRNA transcriptome analysis- Application note
Using a nasopharyngeal carcinoma case study, this paper highlights the integrated transcriptome analysis capabilities of Strand NGS demonstrating the... -
Integrative RNA and ChIP-Seq analysis of regulatory T-cells- Application note
Integrative RNA and ChIP-Seq analysis of regulatory T-cells , a Strand NGS application note that describes how integrated multi-omics functionality in... -
25/02 webinar-An integrated RNA &DNA approach to unravel genetic regulation in cancer
Live webinar on 'An integrated RNA and DNA approach to unravel genetic regulation in cancer'
Abstract
Whole exome DNA sequencing... -
Agilent and Strand to present webinar on 'Integrated Multi-Omics Analysis'
Last edited by Strandlife; 11-12-2014, 09:52 PM.